Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 13, 2020

View Archived Issues

In AML, collapse prevents relapse

Notable responses seen in COVID-19 patients with respiratory failure given RLF-100

Daiichi Sankyo describes new SIRT6 activators

G protein-coupled receptor 35 modulators discovered at Precision IBD

Novartis presents NLRP3 inflammasome inhibitors

Merck KGaA discovers dual adenosine A2A/A2B receptor antagonists

Discovery and preclinical evaluation of anticancer agent, PVHD-303

First-in-human data presented for [68Ga]P15-041 radiotracer

Yumanity Therapeutics identifies stearoyl-CoA desaturase 1/5 inhibitors

VBL announces second successful pre-planned interim analysis of the phase III OVAL study

First patient enrolled in phase III InPedILD study of nintedanib

FDA approves Viltepso for the treatment of DMD in patients amenable to exon 53 skipping therapy

First phase I study of ATG-017 approved in Australia

Recombinant SARS-CoV-2 S1-Fc fusion protein shows promise in animal species

Treadwell initiates phase II study of CFI-400945 and durvalumab in TNBC

TREM2 targeting can synergize with checkpoint blockade

Phase I study results support further evaluation of yellow fever monoclonal antibody TY-014

Bio-Path begins dosing in amended stage 2 of phase II prexigebersen study in AML

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...